Founded
1996
Team Size
5000
Total Funding
₹200 Cr
Valuation
₹4,000 Cr
About
Thyrocare is a diagnostic lab chain in India.
Unique Selling Proposition
Core Differentiator
Thyrocare offers affordable and accessible diagnostic services across India.
Target Market
Middle-class and upper-middle-class families seeking health diagnostics.
Key Innovation
High-volume, low-cost testing model that leverages automation.
Competitive Moats
💰Cost Advantage
Strong
Operational efficiency leads to lower costs for diagnostic services.
⭐Brand
Medium
Established presence and trust in the diagnostics market.
Recent News
PharmEasy-Owned Thyrocare To Exit Radiology, Sell Nueclear Healthcare For ₹141 Cr
Inc42· 2026-09-21
mention
PharmEasy Claims To Be Debt Free After Paring More Stake In Thyrocare
Inc42· 2026-08-17
mention
PharmEasy-Owned Thyrocare’s Q1 Profit Soars 34% To ₹51 Cr
Inc42· 2026-07-23
mention
PharmEasy-Owned Thyrocare’s Q4 Profit Jumps 128% YoY To ₹48.7 Cr
Inc42· 2026-05-07
mention
Details
VedAI Score
645/1000
Developing
Score trend & 9-pillar radar available to members
Sign in to unlock →Thyrocare
HealthTech